Figure 2

Pefloxacin and its derivative, novel inhibitors of the SARS-CoV-2 Main protease (3CLpro) and their pharmacokinetics prediction: An in silico analysis

Emmanuel Oluwaseun Adediran*

Published: 12 July, 2022 | Volume 6 - Issue 1 | Pages: 013-018

apps-aid1030-g002

Figure 2:

Interaction of 1-ethyl-6-fluro-7-(4-(N-substitutedcarbamoylmethylphenyl)piperazyn-1-yl)-4-oxoquinoline-3-carboxylic acid with 3CLpro(Main protease) and the key amino acid residues

Read Full Article HTML DOI: 10.29328/journal.apps.1001030 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?